Immediate Impact

7 from Science/Nature 59 standout
Sub-graph 1 of 22

Citing Papers

Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2024 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
3 intermediate papers

Works of Eluzai Hakim being referenced

The prevalence of and risk factors for atopy in early childhood: A whole population birth cohort study
1998
Sensitization to Alternaria and Cladosporium by the age of 4 years
1996
and 1 more

Author Peers

Author Last Decade Papers Cites
Eluzai Hakim 615 626 202 216 12 1.2k
S Dold 533 314 188 134 17 989
Michael Burr 635 302 332 92 29 1.1k
Manuel E. Soto-Quirós 983 242 455 124 26 1.4k
N. Khaltaev 707 489 428 110 22 1.3k
Chun-Yan Lai 877 335 563 105 18 1.4k
Maritta Kilpeläinen 785 319 599 141 41 1.4k
A. Grübl 474 798 82 263 39 1.4k
William Berger 885 732 406 131 25 1.2k
William F. Schoenwetter 556 447 302 162 28 895
Sheelagh Martindale 529 103 242 45 14 1.3k

All Works

Loading papers...

Rankless by CCL
2026